| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 07/15/2003 | US6593292 Amidine and/or guanidine substituted peptoid and drug conjugates for drug delivery across endo/epithelial tissue |
| 07/15/2003 | US6593291 Inhibition of endothelial cell proliferation inhibits neovascularization |
| 07/15/2003 | US6593133 Neurotrophic factors |
| 07/15/2003 | US6593109 Culturing cells containing DNA sequences under the control of a regulatory sequence capable of directing expression; useful in treating bone defects, healing bone injury and wounds |
| 07/15/2003 | US6592907 Treating an eye infections; cleansing a contact lens in place on an eye |
| 07/15/2003 | US6592892 Flushable disposable polymeric products |
| 07/15/2003 | US6592891 Plaster for topical use containing heparin and diclofenac |
| 07/15/2003 | US6592890 Conveyance of anti-infective activity to wound dressings |
| 07/15/2003 | US6592879 Sacrificial enzyme substrate system, an enzyme inhibitor system or mixtures or combinations thereof, where the composition reduces skin irritation due to enzyme activity. |
| 07/15/2003 | US6592868 Produced by hybridoma having ATCC Accession Number HB 10916 |
| 07/15/2003 | US6592860 Composition and applicator for topical substance delivery |
| 07/15/2003 | CA2238465C Triaromatic compounds, compositions containing them and uses |
| 07/15/2003 | CA2218766C Bicyclic-aromatic compounds |
| 07/10/2003 | WO2003056332A1 Diagnostic for scleroderma |
| 07/10/2003 | WO2003056331A1 Drugs for ameliorating itch, rough skin or hypersensitive skin or for whitening via inhibition of the production and release of stem cell factor |
| 07/10/2003 | WO2003055990A2 Method for culturing and expansion of mammalian undifferentiated epidermal keratinocytes exhibiting stem cell characteristics |
| 07/10/2003 | WO2003055913A2 Secreted protein |
| 07/10/2003 | WO2003055912A2 Secreted proteins |
| 07/10/2003 | WO2003055884A1 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-carboxamide derivatives, their preparation and therapeutic use |
| 07/10/2003 | WO2003055882A1 Pyrrolopyrimidines as phosphodiesterase vii inhibitors |
| 07/10/2003 | WO2003055877A1 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer's disease and conditions associated with glycogen synthase kinase-3 |
| 07/10/2003 | WO2003055876A1 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 07/10/2003 | WO2003055868A1 Benzothiazole- and benzoxazole-4,7-dione derivatives and their use as cdc25 phosphatase inhibitors |
| 07/10/2003 | WO2003055867A1 Biphenylmethyl-thiazolidinediones and analogues and their use as ppar-gamma activators |
| 07/10/2003 | WO2003055865A1 Quinazolinone derivative |
| 07/10/2003 | WO2003055856A2 BICYCLIC LACTAM DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-α CONVERTING ENZYME (TACE) |
| 07/10/2003 | WO2003055536A1 A wound care device |
| 07/10/2003 | WO2003055503A1 Active agent mixture containing a plant extract of convolvulaceae for treating hair problems, skin disorders and skin diseases |
| 07/10/2003 | WO2003055495A1 ORAL PHARMACEUTICAL PRODUCTS CONTAINING 17β-ESTRADIOL-3-LOWER ALKANOATE, METHOD OF ADMINISTERING THE SAME AND PROCESS OF PREPARATION |
| 07/10/2003 | WO2003055492A1 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer's disease and conditions associated with glycogen synthase kinase-3 |
| 07/10/2003 | WO2003055488A1 Remedies or preventives for diseases in association with tissue fibrosis |
| 07/10/2003 | WO2003055481A1 Organ fibrosis inhibitors |
| 07/10/2003 | WO2003055472A1 Gel comprising at least a retinoid and benzoyl peroxide |
| 07/10/2003 | WO2003055463A1 Composition comprising at least an oxazolin for inhibiting langerhans cell migration, and uses thereof |
| 07/10/2003 | WO2003055462A2 Composition comprising at least an alkanolamide for inhibiting langerhans cell migration, and uses thereof |
| 07/10/2003 | WO2003055456A1 Stable surfactant compositions for suspending components |
| 07/10/2003 | WO2003055454A1 New composition |
| 07/10/2003 | WO2003055447A2 Heterocyclic acridone inhibitors of impdh enzyme |
| 07/10/2003 | WO2003055445A2 Compositions and methods for enhancing corticosteriod delivery |
| 07/10/2003 | WO2003055440A2 Compositions and methods for the treatement of immune related diseases |
| 07/10/2003 | WO2003050119A3 Urea substituted imidazopyridines |
| 07/10/2003 | WO2003035107A8 Enzyme inhibitors for inactivating allergens |
| 07/10/2003 | WO2003020203A3 Hydrogenated castor oil dispersed in a lipid for pharmaceutically elegant topical ointments |
| 07/10/2003 | WO2003004511A3 Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals |
| 07/10/2003 | WO2002100354A8 Pyrrolo[2,3-d]pyrimidine nucleoside analogs |
| 07/10/2003 | WO2002046409A3 Proteins and nucleic acids encoding same |
| 07/10/2003 | US20030131370 Disruption of the glutathione S-transferase-Omega-1 gene |
| 07/10/2003 | US20030131363 Controlling the activation of genetic translation, cell proliferation, especially hematopoietic cells; drug screening for compounds which alter the activity of the kinase; thalassemias, sickle cell disease, unstable hemoglobins |
| 07/10/2003 | US20030130515 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo[1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity |
| 07/10/2003 | US20030130508 3,5-bis(trifluoromethyl)phenylmethylene-substituted derivatives of nicotamide or pyridinylaminocarbonyl compounds; used to treat disorders of the central nervous system such as anxiety, depression and psychosis. |
| 07/10/2003 | US20030130505 Nonsteroidal agonists and antagonists |
| 07/10/2003 | US20030130339 Such as (E)-2-pyridineethenyl-4-fluorobenzyl sulfone; antitumor/anticancer agents |
| 07/10/2003 | US20030130335 Protein tyrosine phosphatases inhibitors |
| 07/10/2003 | US20030130333 Combination product and methods of use |
| 07/10/2003 | US20030130294 Pyrimidine 3-oxide compounds for inducing/stimulating hair growth and/or retarding hair loss |
| 07/10/2003 | US20030130292 Immunosuppressants; autoimmune disease; skin disorders; Crohn's disease; antidiabetic agents; anticancer agents; antiarthritic agents |
| 07/10/2003 | US20030130286 Antiproliferative agents; anticancer agents; central nervous system disorders; antiarthritic agents |
| 07/10/2003 | US20030130285 Controlling cell differentiation, cell proliferation |
| 07/10/2003 | US20030130273 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE) |
| 07/10/2003 | US20030130271 1,3-Diheterocyclic metalloprotease inhibitors |
| 07/10/2003 | US20030130254 Respiratory system disorders; antihistamines; antiarthritic agents |
| 07/10/2003 | US20030130250 Methods to mobilize progenitor/stem cells |
| 07/10/2003 | US20030130247 Compositions and methods for enhancing corticosteroid delivery |
| 07/10/2003 | US20030130237 Lysophosphatidic acid receptor antagonist; anticancer agents |
| 07/10/2003 | US20030130236 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 07/10/2003 | US20030130235 3-[4-Substituted heterocyclyl)-pyrrol-2-ylmethylidene]-2- indolinone derivatives as kinase inhibitors |
| 07/10/2003 | US20030130232 Amidine derivatives, the preparation and use thereof as medicaments with LTB4 antagonistic effect |
| 07/10/2003 | US20030130225 Urogenital disorders; concurrent administering fluconazole by mouth and topical applying fungicide in situ |
| 07/10/2003 | US20030130209 Method of treatment of myocardial infarction |
| 07/10/2003 | US20030130201 Mixture with ascorbic acid, proline and lysine |
| 07/10/2003 | US20030130182 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/10/2003 | US20030130168 Reverse-turn mimetics and methods relating thereto |
| 07/10/2003 | US20030129645 Can be used as models for the development of human therapeutic targets, aid in the identification of therapeutic proteins, and serve as targets for the development of human therapeutic agents that modulate kinase activity |
| 07/10/2003 | US20030129606 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
| 07/10/2003 | US20030129294 Hydroquinone-substituted fatty acid for use in foods; lipase inhibitors; peroxisome proliferator activated receptors; antiaging agents |
| 07/10/2003 | US20030129268 Use of at least a fatty ester for preparing a composition designed to inhibit 5-$g(a)-reductase activity, in pharmacology, in particular dematology, in cosmetics and as food additive |
| 07/10/2003 | US20030129266 Interleukin-4 production inhibitors |
| 07/10/2003 | US20030129265 Interleukin-4 production inhibitors |
| 07/10/2003 | US20030129251 Polynucleotide of an immunostimulatory sequence linked to a biodegradable microcarrier |
| 07/10/2003 | US20030129209 Topical application of cetirizine and loratadine |
| 07/10/2003 | US20030129205 Inducing presensitization of immune system towards an immunogen carrying lymphocytes epitope homologous to allergen; immunosuppressants |
| 07/10/2003 | US20030129181 Hydrolases modified by polyoxyethylene glycol for induction of high plasmatic levels of free tumor necrosis factor |
| 07/10/2003 | US20030129172 Animal growth regulator |
| 07/10/2003 | US20030129150 Cosmetic preparations containing plant extracts |
| 07/10/2003 | US20030129129 Prevention, therapy disease; forming tritiated water; calibration |
| 07/10/2003 | CA2472121A1 Composition comprising at least an alkanolamide for inhibiting langerhans cell migration, and uses thereof |
| 07/10/2003 | CA2471713A1 Benzothiazole- and benzoxazole-4,7-dione derivatives and their use as cdc25 phosphatase inhibitors |
| 07/10/2003 | CA2471348A1 Quinazolinone derivative |
| 07/10/2003 | CA2471306A1 Secreted proteins |
| 07/10/2003 | CA2471097A1 A wound care device |
| 07/10/2003 | CA2470666A1 Secreted protein |
| 07/10/2003 | CA2458751A1 Compositions and methods for the treatement of immune related diseases |
| 07/09/2003 | EP1325914A1 Tetrahydroquinoline compounds |
| 07/09/2003 | EP1325903A1 2,3-diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage |
| 07/09/2003 | EP1325750A1 Preparation of medicines (not lotions) based on olive oil for use as hair growth aid and aid to digestion |
| 07/09/2003 | EP1325738A2 Topical lightening compositions and methods of use |
| 07/09/2003 | EP1325737A1 Skin pore minimizers and skin elasticity improvers |
| 07/09/2003 | EP1325122A2 Modulation of the transcription of pro-inflammatory gene products |
| 07/09/2003 | EP1325117A2 Lipid metabolism enzymes |
| 07/09/2003 | EP1325060A1 Soybean-based thermoplastics as biomaterials |